Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis
- PMID: 22209079
- DOI: 10.1016/j.cyto.2011.12.005
Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis
Abstract
Rheumatoid arthritis (RA) is an inflammatory disease is one of the most serious medical problems, affecting ∼1% of all people worldwide, irrespective of race. The disease is autoimmune in nature and characterized by chronic inflammation of the synovial tissues in multiple joints that leads to joint destruction. Although T cells are central players in RA development, B cells are required for full penetrance of disease largely via their production of autoantibodies against Fc domain of IgG rheumatoid factor (RF). Treatment options for RA are limited and if any, are inadequate due to associated side effects. Members of the tumor necrosis factor (TNF) superfamily play important roles in a number of autoimmune diseases, including RA. In this review, we briefly summarize key features of the superfamily, we will consider how the well-characterized members concerned with immune regulation are coordinated and their roles in rheumatoid arthritis.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Similar articles
-
Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.Arthritis Res Ther. 2006;8(3):R64. doi: 10.1186/ar1926. Epub 2006 Mar 28. Arthritis Res Ther. 2006. PMID: 16569263 Free PMC article.
-
B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives.Autoimmun Rev. 2011 Nov;11(1):28-34. doi: 10.1016/j.autrev.2011.06.010. Epub 2011 Jul 14. Autoimmun Rev. 2011. PMID: 21777703 Review.
-
The TNF superfamily member LIGHT contributes to survival and activation of synovial fibroblasts in rheumatoid arthritis.Rheumatology (Oxford). 2007 Jul;46(7):1063-70. doi: 10.1093/rheumatology/kem063. Epub 2007 Apr 10. Rheumatology (Oxford). 2007. PMID: 17426140
-
Blocking of CD27-CD70 pathway by anti-CD70 antibody ameliorates joint disease in murine collagen-induced arthritis.J Immunol. 2009 Sep 15;183(6):3770-7. doi: 10.4049/jimmunol.0901637. Epub 2009 Aug 26. J Immunol. 2009. PMID: 19710474
-
Immunological therapies for rheumatoid arthritis.Br Med Bull. 2005 Sep 20;73-74:71-82. doi: 10.1093/bmb/ldh051. Print 2005. Br Med Bull. 2005. PMID: 16174791 Review.
Cited by
-
Alternative expression pattern of MALT1-A20-NF-κB in patients with rheumatoid arthritis.J Immunol Res. 2014;2014:492872. doi: 10.1155/2014/492872. Epub 2014 May 26. J Immunol Res. 2014. PMID: 24971370 Free PMC article.
-
The non-canonical NF-κB pathway in immunity and inflammation.Nat Rev Immunol. 2017 Sep;17(9):545-558. doi: 10.1038/nri.2017.52. Epub 2017 Jun 5. Nat Rev Immunol. 2017. PMID: 28580957 Free PMC article. Review.
-
Distinct effects of methotrexate and etanercept on the B cell compartment in patients with juvenile idiopathic arthritis.Arthritis Rheumatol. 2014 Sep;66(9):2590-600. doi: 10.1002/art.38736. Arthritis Rheumatol. 2014. PMID: 24909567 Free PMC article.
-
Targeted genomic analysis reveals widespread autoimmune disease association with regulatory variants in the TNF superfamily cytokine signalling network.Genome Med. 2016 Jul 19;8(1):76. doi: 10.1186/s13073-016-0329-5. Genome Med. 2016. PMID: 27435189 Free PMC article.
-
TNF Signaling Impacts Glucagon-Like Peptide-1 Expression and Secretion.J Mol Endocrinol. 2018 Oct 15;61(4):153-161. doi: 10.1530/JME-18-0129. J Mol Endocrinol. 2018. PMID: 30021757 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical